Search Results - "GOSS, C"

Refine Results
  1. 1

    Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection by Clancy, J P, Dupont, L, Konstan, M W, Billings, J, Fustik, S, Goss, C H, Lymp, J, Minic, P, Quittner, A L, Rubenstein, R C, Young, K R, Saiman, L, Burns, J L, Govan, J R W, Ramsey, B, Gupta, R

    Published in Thorax (01-09-2013)
    “…Arikace is a liposomal amikacin preparation for aerosol delivery with potent Pseudomonas aeruginosa killing and prolonged lung deposition. To examine the…”
    Get more information
    Journal Article
  2. 2

    The age, isotopic signature and significance of the youngest Mesozoic granitoids in the Jiaodong Terrane, Shandong Province, North China Craton by Goss, Sarah C., Wilde, Simon A., Wu, Fuyuan, Yang, Jinhui

    Published in Lithos (01-12-2010)
    “…Most Cretaceous granitoids in the Jiaodong Terrane of Shandong Province, North China Craton, were intruded between ~ 130 and 122 Ma. However, four granitoid…”
    Get full text
    Journal Article
  3. 3

    Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation by Goss, Victoria M, Dushianthan, Ahilanandan, McCorkell, Jenni, Morton, Katy, Goss, Kevin C W, Marsh, Michael J, Pappachan, John V, Postle, Anthony D

    “…Acute lung Injury leads to alterations in surfactant lipid composition and metabolism. Although several mechanisms contribute to dysregulated surfactant…”
    Get full text
    Journal Article
  4. 4

    Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli by Kuhlmann, F M, Laine, R O, Afrin, S, Nakajima, R, Akhtar, M, Vickers, T, Parker, K, Nizam, N N, Grigura, V, Goss, C W, Felgner, P L, Rasko, D A, Qadri, F, Fleckenstein, J M

    Published in Infection and immunity (16-04-2021)
    “…Enterotoxigenic (ETEC) contributes significantly to the substantial burden of infectious diarrhea among children living in low- and middle-income countries. In…”
    Get full text
    Journal Article
  5. 5

    C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response by VanDevanter, DR, Heltshe, SL, Skalland, M, West, NE, Sanders, DB, Goss, CH, Flume, PA

    Published in Journal of cystic fibrosis (01-07-2022)
    “…•C-reactive protein (CRP) is a biomarker of systemic inflammation of interest in CF.•We studied CRP as a biomarker of response to pulmonary exacerbation (PEx)…”
    Get full text
    Journal Article
  6. 6

    Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus by Banerjee, Sujoy, Fernandez, Ramon, Fox, Grenville F., Goss, Kevin C. W., Mactier, Helen, Reynolds, Peter, Sweet, David G., Roehr, Charles C.

    Published in Pediatric research (01-07-2019)
    “…Our aim was to develop consensus recommendations from United Kingdom (UK) neonatal specialists on the use of surfactant for the management of respiratory…”
    Get full text
    Journal Article
  7. 7

    Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation by Sanders, D.B., Khan, U., Heltshe, S.L., Skalland, M., West, N.E., VanDevanter, D.R., Goss, C.H., Flume, P.A.

    Published in Journal of cystic fibrosis (01-07-2022)
    “…•The impact of home vs hospital care is an important clinical question in the treatment of pulmonary exacerbations (PEx).•We assessed treatment responses for…”
    Get full text
    Journal Article
  8. 8

    Assessing the profile and utility of diplomates in occupational medicine by Johnson, F, Madan, I, Pattani, S, De Bono, A, Boorman, S, Goss, C, Parsons, V

    Published in Occupational medicine (Oxford) (09-05-2024)
    “…The utility of the occupational medicine diploma in the UK is yet to be explored. The NHS 'Growing Occupational Health (OH) and Wellbeing' programme provides…”
    Get full text
    Journal Article
  9. 9

    Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis by Goss, C H, Mayer-Hamblett, N, Aitken, M L, Rubenfeld, G D, Ramsey, B W

    Published in Thorax (01-11-2004)
    “…Background:Stenotrophomonas maltophilia (SM) is a Gram-negative non-fermenting bacteria cultured from the sputum of patients with cystic fibrosis (CF). To…”
    Get full text
    Journal Article
  10. 10

    Comparison of three solid phase extraction sorbents for the isolation of THM precursors from manitoban surface waters by Goss, C.D., Wiens, R., Gorczyca, B., Gough, K.M.

    Published in Chemosphere (Oxford) (01-02-2017)
    “…Three prepackaged solid phase extraction (SPE) cartridges: two modified styrene divinylbenzene, Bond Elut ENV and Bond Elut PPL (Varian), and one…”
    Get full text
    Journal Article
  11. 11

    Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment by VanDevanter, DR, Heltshe, SL, Sanders, DB, West, NE, Skalland, M, Flume, PA, Goss, CH

    Published in Journal of cystic fibrosis (01-01-2021)
    “…•The STOP-OB study collected respiratory symptom changes with exacerbation treatment.•Symptoms were collected by Chronic Respiratory Infection Symptom Score…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Antipseudomonal treatment decisions during CF exacerbation management by VanDevanter, D.R., West, N.E., Sanders, D.B., Skalland, M., Goss, C.H., Flume, P.A., Heltshe, S.L.

    Published in Journal of cystic fibrosis (01-09-2022)
    “…•Exacerbation treatment outcomes for STOP2 subjects with P. aeruginosa were studied.•Outcomes were compared across number of antipseudomonal classes used.•Lung…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Postnatal adaptations of phosphatidylcholine metabolism in extremely preterm infants: implications for choline and PUFA metabolism by Goss, Kevin CW, Goss, Victoria M, Townsend, J Paul, Koster, Grielof, Clark, Howard W, Postle, Anthony D

    Published in The American journal of clinical nutrition (01-12-2020)
    “…Lipid metabolism in pregnancy delivers PUFAs from maternal liver to the developing fetus. The transition at birth to diets less enriched in PUFA is especially…”
    Get full text
    Journal Article
  17. 17

    Duration of Antibiotic Therapy in Non-cystic Fibrosis Bronchiectasis by Somayaji, R., Goss, C. H.

    Published in Current pulmonology reports (01-12-2019)
    “…Purpose of Review We conducted a review of the current evidence relating to antibiotic duration in the short- and long-term management of non-cystic fibrosis…”
    Get full text
    Journal Article
  18. 18

    Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis by VanDevanter, D.R, Heltshe, S.L, Spahr, J, Beckett, V.V, Daines, C.L, Dasenbrook, E.C, Gibson, R.L, Jain, R, Sanders, D.B, Goss, C.H, Flume, P.A

    Published in Journal of cystic fibrosis (01-09-2017)
    “…Abstract Background Given the variability in pulmonary exacerbation (PEx) management within and between Cystic Fibrosis (CF) Care Centers, it is possible that…”
    Get full text
    Journal Article
  19. 19

    Exacerbations in cystic fibrosis · 1 : Epidemiology and pathogenesis by GOSS, Christopher H, BURNS, Jane L

    Published in Thorax (01-04-2007)
    “…With the improving survival of patients with cystic fibrosis (CF), the clinical spectrum of this complex multisystem disease continues to evolve. One of the…”
    Get full text
    Journal Article
  20. 20

    People-centred care: new research needs and methods in doctor–patient communication. Challenges in mental health by Del Piccolo, L., Goss, C.

    Published in Epidemiology and psychiatric sciences (01-06-2012)
    “…Communication in psychiatry is nowadays called to create bridges between different levels of observation (biological, functional and relational levels) and…”
    Get full text
    Journal Article